Press Releases

CARLSBAD, Calif., Nov. 14, 2019 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced net income of $96,000, or $0.01 per diluted share, on net sales of $2

GARDNER, Mass., Nov. 14, 2019 /PRNewswire/ -- Precision Optics Corporation, Inc. (OTCQB: PEYE), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, announced operating results on an unaudited basis for its first quarter fiscal year ended September 30, 2019.First quarter f

HACKENSACK, N.J., Nov. 14, 2019 /PRNewswire/ -- Hackensack Meridian Health Hackensack University Medical Center today announced that Andrew L. Pecora, M.D., FACP, CPE, a nationally recognized hematologist/oncologist, will be presenting two abstracts at the prestigious

LONG BEACH, Calif., Nov. 14, 2019 /PRNewswire/ -- MemorialCare Miller Children's & Women's Hospital Long Beach has named Susan Herman, DNP, MSN, RN, NEA-BC, CENP, as its new Chief Nursing Officer. With more than 12 years of experience in a pediatric academic environment, Herman is a transformational leader who creates a patient-centered

FRANKLIN LAKES, N.J., Nov. 14, 2019 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the Jefferies 2019 London Healthcare Conference on Thursday, November 21, 2019, at 6:20 a.m. ET.A live webcast of BD

- "Building Momentum for Patients with Myelofibrosis" scheduled for 6:00 p.m. GMT on November 20, 2019 - VANCOUVER, Nov. 14, 2019 /PRNewswire/ - Sierra Oncology, Inc. (Nasdaq: SRRA), a late-stage drug development company focused on the development and commercialization of momelotinib, a JA

DUBLIN, Nov. 14, 2019 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will webcast its corporate presentations at three upcoming investor conferences.Jefferies 2019 London Healthcare Conference in London, UK on Thursday, November 21, 2019 at

SAN FRANCISCO, Nov. 14, 2019 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, will participate in the Stifel Healthcare Conference on November 19 in New York City and Jefferies London Healthcare Confer

SAN DIEGO, Nov. 14, 2019 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that Barry Quart, Pharm.D., President and Chief Executive Officer of Heron Therapeutics,

SOUTH SAN FRANCISCO, Calif., Nov. 14, 2019 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) today reported financial results for the third quarter ended September 30, 2019 and provided an update on its business.